EMERALD MUTUAL FUND ADVISERS TRUST - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$8,619,000
-21.5%
129,878
-5.8%
0.38%
-12.4%
Q2 2019$10,973,000
-11.5%
137,898
+24.4%
0.44%
-12.3%
Q1 2019$12,396,000
+83.4%
110,818
-4.2%
0.50%
+84.8%
Q4 2017$6,758,000
-5.3%
115,679
+76.2%
0.27%
-20.9%
Q4 2016$7,133,000
-31.5%
65,654
+3.8%
0.34%
-35.8%
Q3 2016$10,408,000
+75.8%
63,233
+52.4%
0.53%
+59.6%
Q2 2016$5,920,000
+163.8%
41,491
+137.5%
0.33%
+163.5%
Q1 2016$2,244,000
-43.1%
17,470
-33.8%
0.13%
-39.4%
Q4 2015$3,943,000
-48.1%
26,400
-42.4%
0.21%
-58.1%
Q3 2015$7,600,000
-8.4%
45,820
+33.3%
0.50%
-22.5%
Q2 2015$8,295,000
-20.0%
34,364
-11.4%
0.64%
-24.6%
Q1 2015$10,367,000
+65.2%
38,799
-3.5%
0.85%
+56.0%
Q4 2014$6,275,000
+63.2%
40,227
+147.6%
0.54%
+54.4%
Q2 2014$3,845,000
-56.5%
16,248
-39.4%
0.35%
-58.3%
Q1 2014$8,845,000
-22.2%
26,821
-73.4%
0.85%
+24.6%
Q4 2013$11,368,000
-9.1%
100,717
-44.4%
0.68%
-21.4%
Q3 2013$12,506,000
+1087.7%
181,162
+671.7%
0.86%
+385.4%
Q2 2013$1,053,00023,4760.18%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$9,514,0001.49%
CM Management, LLC 45,000$668,0000.50%
EULAV Asset Management 660,000$9,801,0000.26%
DLD Asset Management, LP 225,200$3,346,0000.24%
Virtus ETF Advisers LLC 21,387$318,0000.14%
GSA CAPITAL PARTNERS LLP 79,145$1,175,0000.12%
Hennion & Walsh Asset Management, Inc. 136,720$2,030,0000.11%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$2,507,0000.08%
Inspire Investing, LLC 31,868$473,0000.06%
DUALITY ADVISERS, LP 51,196$760,0000.06%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders